The DOI matches its Crossref record; the references it cites are not checked yet.
Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial
Abstract
This investigation was conducted to evaluate comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome (PCOS). This randomized controlled trial was conducted on 53 women with PCOS, aged 18-40 years old. Subjects were randomly allocated into two groups to take either myo-inositol (n = 26) or metformin (n = 27) for 12 weeks. Myo-inositol supplementation, compared with metformin, significantly reduced fasting plasma glucose (FPG) (β -5.12 mg/dL; 95% CI, -8.09, -2.16; p=.001), serum insulin levels (β -1.49 µIU/mL; 95% CI, -2.28, -0.70; p<.001), homeostasis model of assessment-insulin resistance (β -0.36; 95% CI, -0.55, -0.17; p<.001), serum triglycerides (β 12.42 mg/dL; 95% CI, -20.47, -4.37; p=.003) and VLDL-cholesterol levels (β -2.48 mg/dL; 95% CI, -4.09, -0.87; p=.003), and significantly increased the quantitative insulin sensitivity check index (β 0.006; 95% CI, 0.002, 0.01; p=.006) compared with metformin. Moreover, myo-inositol supplementation upregulated gene expression of peroxisome proliferator-activated receptor gamma (PPAR-γ) (p=.002) compared with metformin. Overall, taking myo-inositol, compared with metformin, for 12 weeks by women with PCOS had beneficial effects on glycemic control, triglycerides and VLDL-cholesterol levels, and gene expression of PPAR-γ.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
The citation lists haven’t been fetched yet
References 41 · Cited by 63
Research works printed but not linked: 5
- Mansour A, 2016, EXCIL J, 15, 551
- Kapral M, 2013, Acta Pol Pharm, 2013, 1
- Gerli S, 2007, Eur Rev Med Pharmacol Sci, 11, 347
- Costantino D, 2009, Eur Rev Med Pharmacol Sci, 13, 105
- Rago R, 2015, J Biol Regul Homeost Agents, 29, 913
Metadata
- Authors
- Shokrpour, M., Foroozanfard, F., Afshar Ebrahimi, F., Vahedpoor, Z., Aghadavod, E., Ghaderi, A., & Asemi, Z.
- Affiliations
- Arak University of Medical Sciences (IR)
- Kashan University of Medical Sciences (IR)
- Department of Gynecology and Obstetrics, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran;
- Corresponding author
- Asemi, Zatollah
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2019-01-04
- Volume
- 35
- Issue
- 5
- Pages
- 406-411
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W2907087060
- Cited by
- 63
- References
- 41
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 11 · 2023: 11 · 2022: 13 · 2021: 5 · 2020: 9 · 2019: 3
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gynecological Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, myo-inositol, metformin, glycemic control, insulin resistance, lipid profile, triglycerides, VLDL cholesterol, PPARγ, gene expression, insulin sensitivity, fasting blood glucose
- MeSH terms
- Adolescent, Adult, Blood Glucose, Female, Humans, Hypoglycemic Agents, Inositol, Insulin, Lipids, Metformin, Polycystic Ovary Syndrome, Gene Expression, Treatment Outcome, Lipid Metabolism, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial. https://app.cochat.ai/papers/10.1080/09513590.2018.1540570
- The paper
- Shokrpour, M., Foroozanfard, F., Afshar Ebrahimi, F., Vahedpoor, Z., Aghadavod, E., Ghaderi, A., & Asemi, Z. (2019). Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial. Gynecological Endocrinology. https://doi.org/10.1080/09513590.2018.1540570
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.